BioHarvest Sciences Inc., a leader in Botanical Synthesis technology, announced its intention to dual-list its ordinary shares on the Tel Aviv Stock Exchange (TASE), with trading expected to begin on September 8, 2026. The company, already listed on the Nasdaq Capital Market, will register all outstanding and potential future shares for the TASE listing, including 22,667,842 outstanding common shares, up to 4,516,021 shares reserved for its equity incentive plan, and 610,742 shares issuable upon exercise of warrants. CEO Dr. Zaki Rakib said the dual listing is a natural step for the Israeli-founded company to broaden access to its shares and strengthen ties with the Israeli investment community. The shares will trade under the symbol BHST in English and "בהסט" in Hebrew, and all future EDGAR filings will also be submitted through the MAGNA Disclosure System.
BioHarvest Sciences Inc. Common StockDual listing on TASE broadens access to shares and strengthens ties with Israeli investors.
